Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Multi-centre, Two-part Study to Evaluate the Safety and Efficacy of Study Drug in Acute Ischaemic Stroke.

NCT00144014 is registered in ClinicalTrials.gov with Vernalis (R&D) Ltd as lead sponsor.

NCT NCT00144014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00144014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Multi-centre, Two-part Study to Evaluate the Safety and Efficacy of Study Drug in Acute Ischaemic Stroke.
Lead sponsor
Vernalis (R&D) Ltd
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2005
Completion date
March 31, 2009
Enrollment
49 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

stroke